Actively Recruiting
Intravesical LGG VS Saline Bladder Wash RCT
Led by Medstar Health Research Institute · Updated on 2025-08-29
120
Participants Needed
1
Research Sites
237 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
This is the first ever comparative effectiveness study of an antibiotic-sparing novel self-management intervention to prevent complicated urinary tract infection (UTI).
CONDITIONS
Official Title
Intravesical LGG VS Saline Bladder Wash RCT
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Age 18 years or older
- Spinal cord injury for at least 6 months
- Diagnosed neurogenic lower urinary tract dysfunction
- Using intermittent catheterization for bladder management
- Living in the community (discharged from acute care)
You will not qualify if you...
- Known genitourinary problems beyond neuropathic bladder, such as reflux or stones
- Use of preventative antibiotics
- Prior use of intravesical agents like gentamycin, saline, or Lactobacillus
- Immunodeficiency conditions
- Oral antibiotics taken within the last 2 weeks
- Psychological or psychiatric issues affecting ability to follow instructions
- Participation in another conflicting clinical study
- Exposure to intravesical LGG within the past 6 months
- Active cancer within 5 years or active autoimmune disorder
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
MedStar National Rehabilitation Hospital
Washington D.C., District of Columbia, United States, 20010
Actively Recruiting
Research Team
E
Emily Leonard, PhD
CONTACT
I
Inger H Ljungberg, MPH
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
PREVENTION
Number of Arms
4
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here